Delivery Order SPE2DB20D3103-SPE2DB23FM0S6

Award Date 1/4/23
Potential Completion Date 1/5/23
Potential Value $3.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,025.79 firm fixed-price delivery order contract is for the supply of TOPROL XL 25 MG tablets to support military healthcare programs. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $4,369.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of TOPROL XL 200 MG Tablets, with an ultimate completion date of March 14, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 1,000 units of Toprol XL 100 mg tablets, with a total potential value of $100,145.43. The product will be delivered to a location in Conshohocken, Pennsylvania. No set-aside designation was used for this award. As a prime contractor for DLA, AmerisourceBergen Drug Corporation...
This federal contract award is for the delivery of Metoprolol Succinate ER 25 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,740.50 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., which is a major pharmaceutical distributor. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $15,190.63 under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award covers the delivery of 4,561,683,565 units of the medication Metoprolol Succinate Extended-Release 25mg tablets. The IDC, which runs through November 2026, enables the DLA to efficiently procure a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,228.13 Firm Fixed Price Delivery Order is for the supply of 4567171084 Metoprolol Succinate ER 100 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,700.59, is a delivery order for the supply of METOPROLOL SUCC ER 25 MG TAB 1000S, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of Metoprolol Succinate Extended-Release 25 mg tablets in quantities of 1,000 per bottle. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award, valued at $2,109.25, is a Firm Fixed Price Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA. This IDC, valued at up to $999,999,999.00,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for $1,308.84 to provide Metoprolol Succinate Extended-Release Tablets, a cardiovascular medication, to support military healthcare programs. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,524.41 firm-fixed-price delivery order is for the supply of 4,562,700 units of Metoprolol Succinate Extended-Release 50 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FM0S6
    Delivery Order

The federal contract award SPE2DB20D3103|SPE2DB23FM0S6, valued at $3,251.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4559502849, TOPROL XL 100 MG TABLET 1000S, a cardiovascular medication. This award is a delivery order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. The IDC serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:28 AM